Vaginal Microbiome Research Consortium for Africa
NCT06662747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-08-03
Summary
1. To characterise vaginal microbial community dynamics (bacterial and fungal) from different geographies in Africa to understand the microbial diversity that occurs in women with stable L. crispatus-dominant versus unstable vaginal microbiota.
2. To identify vaginal communities associated with low levels of inflammation in women from different geographies in Africa
3. To examine prevalence and diversity of HPV types circulating in the different geographies and their interaction with the vaginal microbiota
4. To create a biobank of stored samples that can be used in future studies and for the isolation of regionally representative bacterial strains.
Conditions
- Healthy
Interventions
- DIAGNOSTIC_TEST
-
None - observational study only
No interventions, diagnostics tests for HIV, pregnancy, STIs and BV only
Sponsors & Collaborators
-
Desmond Tutu HIV Foundation
collaborator OTHER -
Kenya Medical Research Institute
collaborator OTHER -
University of Cape Town
lead OTHER
Principal Investigators
-
Brian R Kullin, PhD · Research Officer
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-10-15
- Primary Completion
- 2025-12-31
- Completion
- 2026-10-31
Countries
- Kenya
- South Africa
Study Locations
More Related Trials
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308007 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)
NCT03769688 ·Status: WITHDRAWN ·Phase: PHASE1
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308033 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis
NCT03975569 ·Status: COMPLETED ·Phase: NA
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308046 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal lIve Biotherapeutic RANdomized Trial
NCT06135974 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An Expanded Safety Study of Dapivirine Gel 4789 in Africa
NCT00917904 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Expanded Safety Study of Dapivirine Gel 4759 in Africa
NCT00917891 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs
NCT03767374 ·Status: COMPLETED
-
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT06070454 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel
NCT00304642 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa
NCT00304668 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Longitudinal Study of Vaginal Flora
NCT00340275 ·Status: COMPLETED
-
Transplantation of Vaginal Mikrobiome
NCT04855006 ·Status: COMPLETED ·Phase: NA
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
NCT05666778 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Integrated Genetic and Functional Analysis of the Influence of Menstrual Hygiene Products on Female Health
NCT06519799 ·Status: RECRUITING ·Phase: NA
-
Improving Menstrual and VAginal Health for All
NCT06646185 ·Status: RECRUITING ·Phase: NA
-
Effect of Flourish HEC Vaginal Care System on BV Recurrence and the Vaginal Microbiome
NCT05701722 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022 ·Status: COMPLETED ·Phase: NA
-
A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel
NCT00303576 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity
NCT02445989 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Antibiotics on Penile Microbiome and HIV Susceptibility Study in Ugandan Men
NCT03412071 ·Status: UNKNOWN ·Phase: NA
-
To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women
NCT02862171 ·Status: COMPLETED ·Phase: PHASE3
-
Flourish Vaginal Care System to Establish Neovaginal Microbiome
NCT05372770 ·Status: COMPLETED ·Phase: NA
-
Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis
NCT02365389 ·Status: COMPLETED ·Phase: PHASE2/PHASE3